Gilead Sciences Inc. (GILD)
SIX
Real-time Data
07:00 AM
Day's Range
117.1452 wk Range
98.58Overview - GILD - Gilead Sciences Inc.
Key Statistics
Valuation
Enterprise Value
133.06B
P/E (Trailing)
‪18.68‬
PEG Ratio
‪-0.02‬
Price / Sales (TTM)
‪4.69‬
Price / Book
‪15.10‬
EV / EBITDA
‪11.40‬
Profitability
Gross Margin
‪79.76%‬
Profit Margin
‪-10.63%‬
Operating Margin
‪33.67%‬
Return on Assets
‪14.08%‬
Return on Equity
‪-20.68%‬
Ownership
Shares Outstanding
1.24B
Float
1.23B
Held by Insiders
‪0.11%‬
Held by Institutions
‪92.27%‬
Price stats
Beta
‪0.33‬
50-Day Avg
‪105.83‬
200-Day Avg
‪107.97‬
Dividends
Payout Ratio
‪11.16%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - GILD - Gilead Sciences Inc.
Peers - GILD - Gilead Sciences Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on SIX.
- GILDSIXGilead Sciences Inc.142.96BMarket Cap+10.05%52-week change18.69P/E (Trailing)‪-10.63%‬Profit Margin
- LLYSIXEli Lilly and Company900.27BMarket Cap+44.06%52-week change41.32P/E (Trailing)‪33.52%‬Profit Margin
- JNJSIXJohnson & Johnson527.16BMarket Cap+21.06%52-week change29.18P/E (Trailing)‪21.48%‬Profit Margin
- ROSIXRoche Holding AG299.58BMarket Cap+27.02%52-week change23.90P/E (Trailing)‪19.60%‬Profit Margin
- MRKSIXMerck & Co., Inc.284.44BMarket Cap+32.03%52-week change32.58P/E (Trailing)‪13.58%‬Profit Margin
- NOVNEESIXNovartis AG248.37BMarket Cap+20.72%52-week change22.25P/E (Trailing)‪22.50%‬Profit Margin
- PFESIXPfizer Inc.128.24BMarket Cap+8.04%52-week change36.29P/E (Trailing)‪6.80%‬Profit Margin
Profile Summary - GILD - Gilead Sciences Inc.
About
Gilead Sciences Inc. is a global biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines for serious and life-threatening diseases. The company’s core franchise centers on therapies for HIV and viral hepatitis, including hepatitis B and C, where its antiviral portfolio…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
